Here are five takeaways:
1. Novo Nordisk’s research facilities in Denmark will join forces with a team of MIT researchers, co-led by Giovanni Traverso, MBBCh, PhD, and Prof. Robert S. Langer.
2. Dr. Traverso is a gastroenterologist at Massachusetts General Hospital and instructor of medicine at Harvard Medical School, both in Boston.
3. He is a research affiliate of the Langer Laboratory at MIT.
4. Through the collaboration, MIT and Novo Nordisk aim to develop the next generation of drug delivery devices as an alternative to parenteral or injection-based delivery of peptides.
5. The initial term of the collaboration is three years.
More articles on GI/endoscopy:
GI physician perspective: 3 thoughts on MOC recertification
GI physician leader to know: Dr. Sri Narra of Gastro One
6 GI physicians in the news – Sept. 4, 2015
